REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,958,035 | -53.3% | 4,791,459 | +3.0% | 0.00% | -66.7% |
| Q2 2023 | $117,761,761 | -20.5% | 4,652,776 | +1.2% | 0.00% | -25.0% |
| Q1 2023 | $148,157,786 | +78.5% | 4,599,745 | +2.3% | 0.00% | +100.0% |
| Q4 2022 | $83,001,994 | -28.7% | 4,496,316 | +4.3% | 0.00% | -33.3% |
| Q3 2022 | $116,449,000 | +127.5% | 4,312,896 | +16.5% | 0.00% | +200.0% |
| Q2 2022 | $51,176,000 | -28.0% | 3,703,055 | +1.6% | 0.00% | -50.0% |
| Q1 2022 | $71,084,000 | +20.9% | 3,645,311 | +1.2% | 0.00% | +100.0% |
| Q4 2021 | $58,790,000 | -41.1% | 3,602,297 | +0.5% | 0.00% | -50.0% |
| Q3 2021 | $99,876,000 | -6.7% | 3,584,905 | -0.8% | 0.00% | -33.3% |
| Q2 2021 | $107,082,000 | +8.1% | 3,612,748 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $99,030,000 | +7.8% | 3,543,094 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $91,827,000 | +15.9% | 3,240,171 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $79,251,000 | +12.1% | 3,152,376 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $70,681,000 | +78.9% | 2,894,383 | +8.4% | 0.00% | +50.0% |
| Q1 2020 | $39,508,000 | -3.8% | 2,669,449 | +5.5% | 0.00% | +100.0% |
| Q4 2019 | $41,063,000 | +46.9% | 2,530,046 | +17.7% | 0.00% | 0.0% |
| Q3 2019 | $27,944,000 | -4.2% | 2,149,479 | -4.4% | 0.00% | 0.0% |
| Q2 2019 | $29,172,000 | -12.0% | 2,249,144 | +7.0% | 0.00% | 0.0% |
| Q1 2019 | $33,138,000 | -5.6% | 2,102,700 | +20.5% | 0.00% | -50.0% |
| Q4 2018 | $35,114,000 | -6.2% | 1,744,357 | +15.8% | 0.00% | +100.0% |
| Q3 2018 | $37,444,000 | -7.7% | 1,506,795 | +1.9% | 0.00% | -50.0% |
| Q2 2018 | $40,574,000 | -0.4% | 1,478,112 | +11.8% | 0.00% | 0.0% |
| Q1 2018 | $40,734,000 | -8.2% | 1,322,517 | +6.6% | 0.00% | 0.0% |
| Q4 2017 | $44,353,000 | +57.2% | 1,240,603 | +21.1% | 0.00% | +100.0% |
| Q3 2017 | $28,220,000 | +14.7% | 1,024,335 | +10.0% | 0.00% | 0.0% |
| Q2 2017 | $24,595,000 | +36.2% | 931,623 | +7.3% | 0.00% | 0.0% |
| Q1 2017 | $18,056,000 | +5.6% | 868,118 | +5.1% | 0.00% | 0.0% |
| Q4 2016 | $17,091,000 | +29.9% | 825,652 | +1.7% | 0.00% | 0.0% |
| Q3 2016 | $13,160,000 | +23.5% | 811,823 | +3.6% | 0.00% | 0.0% |
| Q2 2016 | $10,659,000 | -13.3% | 783,706 | +11.3% | 0.00% | 0.0% |
| Q1 2016 | $12,297,000 | -44.9% | 704,340 | +7.9% | 0.00% | 0.0% |
| Q4 2015 | $22,307,000 | +55.3% | 653,010 | +35.3% | 0.00% | 0.0% |
| Q3 2015 | $14,363,000 | +0.1% | 482,612 | +7.6% | 0.00% | 0.0% |
| Q2 2015 | $14,342,000 | +65.6% | 448,457 | +7.3% | 0.00% | 0.0% |
| Q1 2015 | $8,661,000 | +33.2% | 417,772 | +8.8% | 0.00% | – |
| Q4 2014 | $6,503,000 | +5.7% | 383,898 | +20.6% | 0.00% | – |
| Q3 2014 | $6,152,000 | -20.7% | 318,262 | +39.6% | 0.00% | -100.0% |
| Q2 2014 | $7,753,000 | +82.5% | 228,026 | +69.0% | 0.00% | – |
| Q1 2014 | $4,249,000 | – | 134,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |